FR Capital Holdings, L.P. - 28 Dec 2023 Form 4 Insider Report for Notable Labs, Ltd.

Role
10%+ Owner
Signature
/s/ Jeffrey Donnon, Chief Financial Officer of FR Capital Holdings, L.P.
Issuer symbol
N/A
Transactions as of
28 Dec 2023
Net transactions value
-$54,136
Form type
4
Filing time
02 Jan 2024, 17:00:22 UTC
Previous filing
28 Dec 2023
Next filing
03 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NTBL Ordinary Shares, par value NIS 0.35 each Sale $43,146 -21,500 -2.2% $2.01 936,489 28 Dec 2023 See Footnote F1, F2
transaction NTBL Ordinary Shares, par value NIS 0.35 each Sale $10,990 -6,000 -0.64% $1.83 930,489 29 Dec 2023 See Footnote F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 FR Capital Holdings, L.P. (the "Reporting Person") is the investment manager to First Round Capital V, LP, a Delaware limited partnership ("FRCV"), and First Round Capital VIII-F, LP, a Delaware limited partnership ("FRCVIIIF"). Josh Kopelman and William Trenchard are the managing members of the Reporting Person. As of January 2, 2024, FRCV held 381,971 ordinary shares, par value NIS 0.35 each ("Ordinary Shares") of Notable Labs, Ltd. and FRCVIIIF held 549,985 Ordinary Shares. The Reporting Person's and Messrs. Kopelman and Trenchard's beneficial ownership is limited to their pecuniary interest, if any, in such securities.
F2 On December 28, 2023, FRCV sold 7,977 Ordinary Shares and FRCVIIIF sold 13,523 Ordinary shares, each at a weighted average price of $2.0068 per share. These shares were sold in multiple transactions at prices ranging from $1.92 to $2.06, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 On December 29, 2023, FRCV sold 2,224 Ordinary Shares and FRCVIIIF sold 3,776 Ordinary shares, each at a weighted average price of $1.8316 per share. These shares were sold in multiple transactions at prices ranging from $1.82 to $1.8601, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.